Ana Sayfa
Piyasalar
Grafikler ve Fikirler
Algo
Haberler
Store
Aracı Kurumlar
İndir
Ekonomik Takvim
Alım-Satım Sinyalleri
Web Terminali
Heatmap
Arama yapmak için
/
tuşuna basın: @kullanıcı, $sembol, ...
Ara
Giriş yap
Hesap oluştur
Türkçe
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
STOK
#1932
Stoke Therapeutics, Inc. Common Stock
36.6
1
USD
+4.45%
Sektör:
Sağlık Hizmetleri
Baz:
USD
Kar Para Birimi:
USD
Günlük Aralık
Yıllık Aralık
Günlük Değişim
+4.45%
Aylık Değişim
+9.09%
6 aylık değişim
+4.72%
Yıllık Değişim
+391.41%
Önceki Kapanış
35.0
5
Open
36.3
0
Bid
Ask
Low
36.0
2
High
36.6
7
Hacim
175
Piyasalar
ABD Borsası
Sağlık Hizmetleri
STOK
Open full chart
Financials
Overview
Rapor
Statistics
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
36.66 M
37.36 M
44.15 M
46.3 M
54.08 M
59.15 M
—
Valuation ratios
Enterprise value
1.98 B
758.21 M
287.75 M
79.9 M
468.49 M
1.79 B
3.66 B
Price to earnings ratio
—
—
-3.5
-2.46
-6.68
-264.5
-209.92
Price to sales ratio
—
—
28.5
29.36
16.3
10.19
22.26
Price to cash flow ratio
—
—
-11.1
-3.18
-6.86
41.23
87.11
Price to book ratio
—
—
1.91
1.62
2.6
5.33
7.37
Enterprise value to EBITDA ratio
-38.02
-8.83
-2.8
-0.71
-4.72
-95.28
-37.5
Profitability ratios
Return on assets %
-0.18
-0.36
-0.39
-0.46
-0.33
-0.02
-0.03
Return on equity %
-0.18
-0.39
-0.55
-0.66
-0.39
-0.02
-0.04
Return on invested capital %
-2 081.24
-1 656.01
-1 043.32
-841.61
-499.47
-75.46
18.89
Gross margin %
100
100
100
100
100
100
400
Operating margin %
1.77 M
296.78 K
-841.24
-1 307.21
-277.31
-11.16
-4 914.97
EBITDA margin %
1.74 M
293.52 K
-828.78
-1 279.09
-271.36
-10.2
-4 878.39
Net margin %
1.74 M
295.88 K
-814.73
-1 192.47
-243.42
-3.73
-4 591.69
Liquidity ratios
Quick ratio
—
—
—
—
—
—
—
Current ratio
25.73
13.37
7.77
6.99
5.81
5.28
27.2
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
-0
-0
0.05
0.04
0.15
0.53
0.53
Solvency ratios
Debt to assets ratio
0
0.03
—
—
—
—
—
Debt to equity ratio
0
0.03
—
—
—
—
—
Long term debt to total assets ratio
-0
-0
—
—
—
—
—
Long term debt to total equity ratio
-0
-0
—
—
—
—
—
Per share metrics
Operating cash flow per share
—
—
-0.82
-1.84
-1.61
0.77
0.75
EBIT per share
—
—
-2.68
-2.61
-1.88
-0.35
-0.37
EBITDA per share
—
—
-2.64
-2.55
-1.84
-0.32
-0.34
Total debt per share
—
—
—
—
—
—
—
Cash per share
—
—
5.9
4.58
4.02
4.81
19.3
Net current asset value per share
—
—
6.27
4.89
4.31
5.16
20.76
Tangible book value per share
—
—
4.75
3.63
4.24
5.95
22.84
Working capital per share
—
—
5.47
4.19
3.57
4.18
17.66
Book value per share
—
—
4.75
3.63
4.24
5.95
22.84
Haberler
Stoke Therapeutics yönetim kuruluna Clare Kahn’ı atadı
Stoke kazanç raporu yaklaşırken Dravet tedavisine büyük bahis
Canaccord, Stoke Therapeutics için hedef fiyatı 60 dolara yükseltti
Stoke Therapeutics kazancı $0,21 ile beklentilere göre daha kötü, kâr ise beklentilere göre düşük
Rocket Lab Soars, Leads 14 Onto Today's Premium Stock Screens
Orchestra BioMed Holdings, Inc. (OBIO) Surpasses Q4 Earnings and Revenue Estimates
Vertex (VRTX) Moves 8.3% Higher: Will This Strength Last?
Stoke Therapeutics hissesi 39,88 dolarda zirve yaptı
Stoke Therapeutics stock hits 52-week high at 39.88 USD
Dravet çalışmasındaki ilerlemeler odakta
Stoke Therapeutics earnings in focus amid Dravet trial progress
Dianthus Therapeutics, Inc. (DNTH) Stock Jumps 12.0%: Will It Continue to Soar?